Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic…

Overview of attention for article published in Blood, November 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Preparation of crystalline ezatiostat hydrochloride ansolvate form D

Grant US-8841476-B2

United States of America

23 Sep 2014

Compositions and methods for treating myelodysplastic syndrome

Grant US-8759303-B2

United States of America

24 Jun 2014

COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME

Application WO-2013019221-A1

World Intellectual Property Organisation (WIPO)

07 Feb 2013

COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME

Application WO-2013019220-A1

World Intellectual Property Organisation (WIPO)

07 Feb 2013

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.